Trump Media shares rise after Trump says he won't sell-March 2024-www.financetom.com

Trump Media shares rise after Trump says he won't sell

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Trump Media shares rise after Trump says he won't sell

Nov 9, 2024 1:14 PM

WASHINGTON (Reuters) - Shares of Trump Media & Technology Group rose on Friday after U.S. President-elect Donald Trump said he had no intention of selling his shares in the company, which owns his Truth Social media platform.

In a post on Truth Social, Trump rejected what he described as rumors that he was planning to sell shares.

"There are fake, untrue, and probably illegal rumors and/or statements made by, perhaps, market manipulators or short sellers, that I am interested in selling shares of Truth," Trump wrote.

"THOSE RUMORS OR STATEMENTS ARE FALSE. I HAVE NO INTENTION OF SELLING!," Trump added.

Shares of the company were up about 8.7% at $30.15 in midmorning trade on the Nasdaq after earlier rising 12.5%.

On Thursday, shares in the company slumped as speculative bets on Trump winning a second term lost steam a day after his victory over Democrat Kamala Harris.

Previous page： Vanda Pharmaceuticals Seeks US FDA Approval for Bysanti to Treat Schizophrenia, Acute Bipolar I Disorder Next page： OPAL Fuels Sells $8.9 Million Investment Tax Credits

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Vanda Pharmaceuticals Seeks US FDA Approval for Bysanti to Treat Schizophrenia, Acute Bipolar I Disorder

Mar 31, 2025

10:15 AM EDT, 03/31/2025 (MT Newswires) -- Vanda Pharmaceuticals ( VNDA ) said Monday that it submitted a new drug application with the US Food and Drug Administration requesting marketing approval for Bysanti to treat acute bipolar I disorder and schizophrenia. The company started a phase 3 study of the drug as a once-daily add-on treatment for major depressive order...

OPAL Fuels Sells $8.9 Million Investment Tax Credits

Mar 31, 2025

10:15 AM EDT, 03/31/2025 (MT Newswires) -- OPAL Fuels ( OPAL ) said Monday it has completed the sale of $8.9 million in investment tax credits. Sapphire RNG facility, a joint venture in which OPAL holds a 50% stake, generated the credits under the Inflation Reduction Act, the company said. Proceeds from the sale will add to the company's net...

Hudson Pacific Properties Closes $475 Million CMBS Loan

Mar 31, 2025

10:21 AM EDT, 03/31/2025 (MT Newswires) -- Hudson Pacific Properties ( HPP ) said Monday it completed a $475 million commercial mortgage-backed securities financing for a portfolio of six office properties located in its West Coast markets. The loan has a five-year term and an interest rate of 376 basis points over a one-month term secured overnight financing rate, the...

Exclusive-Brookfield nears $9 billion-plus deal for Colonial Pipeline, sources say

Mar 31, 2025

(Reuters) - Brookfield Asset Management ( BAM ) is putting the final touches on a deal to acquire Colonial Pipeline, the largest U.S. fuel transportation system, for more than $9 billion including debt, people familiar with the matter said on Monday. The New York-based asset manager has emerged as the winner of the auction process, which the five owners of...